The metal chelating compounds could efficiently suppress deoxyhypusine hydroxylation in eIF5A, and arrest the progression of cell cycle in mammalian cells, including human cancer cells and HUVEC cells, at the boundary of G1/S [35, 36]. This evidence concerns the gene EIF5A and cancer.